Last verified: April 2026. Regulatory status and clinical references were verified via MHLW records, manufacturer announcements, and peer-reviewed literature. Always confirm product details directly with your clinic.

If you have looked at Botox prices in Tokyo, you have probably noticed a confusing gap: some clinics charge ¥3,500 per area, while others charge ¥20,000 or more. The difference is almost always the brand. Budget clinics use Korean-manufactured botulinum toxins; premium clinics use Allergan Botox Vista, the only brand approved by Japan's health ministry. Both are legal, both are real, but they are not the same product. This guide explains what the difference actually means, and what it does not, so you can make an informed decision before booking.

What Is Allergan Botox Vista?

Botox Vista is Allergan's (now AbbVie's) botulinum toxin type A, approved by Japan's Ministry of Health, Labour and Welfare for cosmetic treatment of frown lines and crow's feet. It is the only botulinum toxin with MHLW approval for cosmetic use in Japan, manufactured in the US and identical to the "Botox Cosmetic" sold globally. MHLW approval means the product has undergone Japanese regulatory review, including local clinical trials, and there is a clear liability pathway through the manufacturer if something goes wrong. In Tokyo, Allergan Botox Vista typically costs ¥15,000 to ¥35,000 per area at English-speaking clinics.

What Are Korean Botulinum Toxins?

Several Korean-manufactured botulinum toxins are widely used in Japanese aesthetic clinics. None are MHLW-approved for cosmetic use in Japan, but Japanese physicians can legally import and use them under their own medical responsibility — standard practice, not a loophole. This does mean the manufacturer liability protections that come with MHLW approval do not apply. Korean brands are cheaper due to lower manufacturing costs and skipping the expensive MHLW approval process; a clinic advertising Botox at ¥3,500 to ¥8,000 per area is almost certainly using one of these.

Nabota (ナボタ) — Daewoong Pharmaceutical

The most established alternative, also sold as Jeuveau in the US where it holds FDA approval. Published clinical studies show comparable efficacy to Allergan Botox, with some evidence of faster onset.

Coretox (コアトックス) — Medytox

Uses a different formulation, containing only the core neurotoxin stabilized with polysorbate rather than human serum albumin. Marketed as reducing antibody-formation risk, though long-term comparative data is limited.

Botulax (ボトラックス) and Innotox (イノトックス) — Hugel / Medytox

Also available at some clinics; Innotox is notable for being a ready-to-use liquid form rather than requiring reconstitution.

Is There a Real Clinical Difference?

  • Onset: A 2024 peer-reviewed study in the Journal of Cosmetic Dermatology found Nabota showed faster onset than Allergan Botox, with visible effects in 85% of subjects within 2 days.
  • Duration: Both Allergan and Korean brands are generally reported to last 3 to 6 months; no published head-to-head study shows a consistent duration advantage for either.
  • Diffusion: Slight differences in how far the toxin spreads from the injection site have been reported, which could matter for precision in small areas, though this remains clinically debated.
  • Antibody formation: Some Korean formulations (particularly Coretox) are designed to minimize complexing proteins, theoretically reducing resistance risk over repeated treatments, but long-term comparative data in aesthetic patients is lacking.

The bottom line: clinical differences between Allergan Botox and well-established Korean brands like Nabota appear small based on available evidence. The meaningful difference for patients is regulatory status and the liability pathway if something goes wrong, not a dramatic gap in efficacy.

How to Tell Which Brand Your Clinic Uses

Ask directly before booking: "Which brand of botulinum toxin do you use? Is it Allergan Botox Vista, or a different product?" In Japanese: 「使用するボトックスの製剤名を教えてください。アラガンのボトックスビスタですか?」

Transparent clinics list each brand separately on their pricing page with different prices — BIANCA Clinic, for example, lists Botox Vista, Coretox, and Innotox as distinct options.

Red flags:

  • The clinic advertises "Botox" at an unusually low price without specifying the brand
  • The clinic refuses to name the product when asked
  • The price seems too low for Allergan (anything under ¥12,000/area is almost certainly not Botox Vista)
  • The English website uses "Botox" generically throughout without distinguishing brands

Botox Brand Price Comparison (Tokyo, 2026)

Brand Manufacturer MHLW Status Typical Price (per area)
Botox Vista Allergan (AbbVie) Approved ¥15,000–¥35,000
Nabota Daewoong Pharmaceutical Not approved (physician-responsibility import) ¥3,500–¥8,000
Coretox Medytox Not approved (physician-responsibility import) ¥3,500–¥8,000
Botulax / Innotox Hugel / Medytox Not approved (physician-responsibility import) ¥3,500–¥8,000

‍

Choosing Your Botox Brand in Tokyo Through Kanbi

Neither choice is wrong: choosing a Korean brand to save money is reasonable if you understand what you're getting, and choosing Allergan for the regulatory reassurance is equally reasonable. What matters is that the decision is yours, made with clear information. Kanbi vets every clinic in its network for brand transparency and confirms exactly which product will be used before you book. Submit a treatment request → kanbicare.com

‍